Ibogaine News and Policy

Ibogaine has had more political movement in the United States in two years than in the previous thirty. Money has been appropriated, laws have passed, and none of it has yet made the drug lawfully available to a single patient.

This section tracks that gap. It is organised around people and instruments rather than around announcements, because announcements are what the field produces most of.

Why this section is about people

Ibogaine policy in America is not a broad movement. It is a small number of named individuals who know each other and appear together, and the same names recur across states.

Americans for Ibogaine, the principal advocacy organisation, is chaired by former Texas governor Rick Perry, with W. Bryan Hubbard as its chief executive. Hubbard previously chaired Kentucky’s opioid abatement commission, where the first state attempt to fund ibogaine research was made and abandoned.

Knowing that one structure connects Texas, Kentucky and the national campaign explains the pattern of announcements better than reading each one separately.

What has actually happened

Nine states have enacted ibogaine legislation since 2025, and none of it has produced access. Three of them account for most of the money and most of the coverage.

Texas passed a framework law in June 2025 and appropriated fifty million dollars separately, in the general appropriations act, as matching funds for FDA-supervised trials. Merging the two is the standard error about Texas, and our own page on it says so. The award went to a university consortium in December 2025, and in March 2026 the state announced it would proceed with its own researchers after receiving no adequate proposal from a drug developer. The detail is on ibogaine and Texas law.

Kentucky enacted a framework over a governor’s veto in April 2026, having lost its proposed forty-two million dollars in committee weeks earlier. Louisiana went the other way, permitting parishes to spend opioid settlement funds to enrol residents in studies covering ibogaine, and Mississippi’s legislators expect to appropriate settlement money for theirs. Oklahoma enacted a near-identical mechanism a month later, without money. Neither creates a route to treatment.

Then the federal government moved, which the state story had spent two years implying was impossible.

An executive order signed on 18 April 2026 and published four days later names ibogaine twice. It directs the Food and Drug Administration and the Drug Enforcement Administration to establish a pathway for eligible patients to reach psychedelic drugs, ibogaine compounds among them, under the Right to Try Act, including any Schedule I handling authorisations that requires. It also directs at least fifty million dollars through the federal health research agency.

Ibogaine had already been named in federal statute once, in the 2024 defence authorisation, which listed it among the substances a Department of Defense study programme may examine for post-traumatic stress and traumatic brain injury.

How the case is being made

The advocacy is built around veterans, and its leadership is candid about why.

Speaking at a South by Southwest panel in March 2026, Rick Perry described the reasoning directly: the veteran population is, in his words, “a very sellable population to go to the legislature with”.

That is a statement about political strategy, made openly by the person running the strategy. We quote it because it explains the shape of the debate, not because it settles anything about whether the drug works.

What this section covers

The Stanford ibogaine study takes apart the result behind almost every favourable headline since 2024, and why one cohort of thirty men keeps arriving as new evidence.

What the executive order actually does is the standing dossier on federal policy: what Executive Order 14401 directs, the three limits that stop it reaching ibogaine today, and the wrong order number that circulates with the story.

Rick Perry and ibogaine sets out what he has done, said and funded. Bryan Hubbard covers the Kentucky attempt, why it failed, and what he does now.

Pages here carry a verification date and are revisited, because this is the part of the site most likely to go out of date.